Management and Extent of Resection for Intrahepatic Cholangiocarcinoma

被引：32

作者：

Carpizo, Darren R. ^{[2
]}

D'Angelica, Michael ^{[1
]}

机构：

[1] Cornell Univ, Dept Surg, Mem Sloan Kettering Canc Ctr, Weill Med Coll, New York, NY 10021 USA

[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Surg, Canc Inst New Jersey, New Brunswick, NJ 08901 USA

来源：

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2009年 / 18卷 / 02期

关键词：

Intrahepatic cholangiocarcinoma; Resection; Biliary cancer; Liver cancer; SINGLE-CENTER EXPERIENCE; PRIMARY SCLEROSING CHOLANGITIS; LONG-TERM SURVIVAL; UNRESECTABLE HEPATOCELLULAR-CARCINOMA; RANDOMIZED CONTROLLED TRIAL; SEER DATABASE ANALYSIS; LYMPH-NODE METASTASES; PRIMARY LIVER-CANCER; PROGNOSTIC-FACTORS; SURGICAL-TREATMENT;

D O I：

10.1016/j.soc.2008.12.010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Intrahepatic cholangiocarcinoma is the second most common primary liver cancer behind hepatocellular cancer. Although it is an uncommon malignancy, several reports have documented a significant rise in incidence, not only in the United States, but worldwide over the last several decades. As a result, interest in understanding the presentation, diagnosis, natural history, and efficacy of various treatment modalities has increased. This article reviews the clinical presentation, preoperative work-up, surgical management, and outcomes of patients undergoing resection for intrahepatic cholangiocarcinoma. Treatment options in unresectable patients are also reviewed.

引用

页码：289 / +

页数：19

共 55 条

[1]

Asakura H, 2005, HEPATO-GASTROENTEROL, V52, P722

[2]

ATIQ OT, 1992, CANCER, V69, P920, DOI 10.1002/1097-0142(19920215)69:4<920::AID-CNCR2820690414>3.0.CO

[3]

2-Y

[4]

Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases [J].

Bodingbauer, M. ;

Tamandl, D. ;

Schmid, K. ;

Plank, C. ;

Schimai, W. ;

Gruenberger, T. .

BRITISH JOURNAL OF SURGERY, 2007, 94 (09) :1133-1138

[5]

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis [J].

Broome, U ;

Olsson, R ;

Loof, L ;

Bodemar, G ;

Hultcrantz, R ;

Danielsson, A ;

Prytz, H ;

SandbergGertzen, H ;

Wallerstedt, S ;

Lindberg, G .

GUT, 1996, 38 (04) :610-615

[6]

Intra-arterial hepatic chemotherapy combined with continuous infusion of 5-fluorouracil in patients with metastatic cholangiocarcinoma [J].

Cantore, M ;

Rabbi, C ;

Guadagni, S ;

Zamagni, D ;

Aitini, E .

ANNALS OF ONCOLOGY, 2002, 13 (10) :1687-1688

[7]

Chuo FF, 1997, HEPATO-GASTROENTEROL, V44, P760

[8]

Cholangiocarcinoma - Thirty-one-year experience with 564 patients at a single institution [J].

DeOliveira, Michelle L. ;

Cunningham, Steven C. ;

Cameron, John L. ;

Kamangar, Farin ;

Winter, Jordan M. ;

Lillemoe, Keith D. ;

Choti, Michael C. ;

Yeo, Charles J. ;

Schulick, Richard D. .

ANNALS OF SURGERY, 2007, 245 (05) :755-762

[9]

Intrahepatic cholangiocardnoma - Rising frequency, improved survival, and determinants of outcome after resection [J].

Endo, Itaru ;

Gonen, Mithat ;

Yopp, Adam C. ;

Dalal, Kimberly M. ;

Zhou, Qin ;

Klimstra, David ;

DAngelica, Michael ;

DeMatteo, Ronald P. ;

Fong, Yuman ;

Schwartz, Lawrence ;

Kemeny, Nancy ;

O'Reilly, Eileen ;

Abou-Alfa, Ghassan K. ;

Shimada, Hiroshi ;

Blumgart, Leslie H. ;

Jarnagin, William R. .

ANNALS OF SURGERY, 2008, 248 (01) :84-96

[10]

Liver transplantation for incidental cholangiocarcinorna:: Analysis of the Canadian experience [J].

Ghali, P ;

Marotta, P ;

Yoshida, EM ;

Bain, VG ;

Marleau, D ;

Peltekian, K ;

Metrakos, P ;

Deschênes, M .

LIVER TRANSPLANTATION, 2005, 11 (11) :1412-1416

← 1 2 3 4 5 6 →